Dr. Jen Gunter

And I'm like, well, what study has been published since 2022 that's not included in the guidelines?

Crickets.

Right.

So, you know, when there's a new study that comes out and is something pretty significant, you know, you get a release, you know, you get a press release from or not a press release.

You get you get something, an email from your professional society that's saying, hey, you know, this study came out and this is super important and we need to put this in context.

I would say maybe.

The data is not great.

And so the problem is that I would say, okay, well, what dose, what formulation, what method of delivery?

Is it oral or transdermal?

And you can't drill down on the studies to get that information.

And a lot of the data that we have comes from oral estrogen, and we don't have that kind of long-term data from transdermal, which is the most common that we prescribe.

So the answer would be maybe.

Maybe it could also be maybe not.

So when you're talking with somebody and you're saying you have hot flashes, you have night sweats, you want to go on menopause hormone therapy, fantastic.

might you get this additional benefit?

Okay, maybe.

But when you're gonna talk about something from a preventative care standpoint where you say everybody should be on it, that's a completely different threshold.

We don't make guidelines about everybody being on something based on maybe.

We say, well, this is what we know.

This is what the evidence says.